Cardiothoracic professionals from around the world gathered at the 61st Annual Meeting of The Society of Thoracic Surgeons (STS) in Los Angeles, held January 24-26, 2025.

As the premier global event for cardiothoracic surgeons, the meeting drew more than 2,000 attendees and featured more than 80 educational sessions. Participants experienced groundbreaking discoveries, hands-on demonstrations of advanced techniques, and cutting-edge technological innovations from industry leaders. 

Pre-conference Sessions Enhanced the Educational Experience

Image
STS 2025 pre-conference

STS offered three concurrent half-day programs on Thursday, Jan. 23. In the Lung Cancer: Clinical Trials Meet Clinical Practice session on early-stage and locally advanced non-small cell lung cancer, attendees received a comprehensive overview of recent diagnostic breakthroughs and key clinical trials through interactive discussions, debates, and case-based tumor board sessions. During the Aortic Universe: From Birth to Adulthood program, participants gained invaluable insights into diagnosing, treating, and managing aortic conditions across all age groups through detailed surgical videos and case-based presentations. The third session, The STS APP Conference — Redesigning the Future Together, focused on innovative approaches to elevate the role of advanced practice providers in cardiothoracic surgery. It highlighted strategies for enhancing clinical management, fostering professional success, and cultivating leadership within the field.

Adult Cardiac Surgery Sessions

Among the Adult Cardiac Surgery Sessions presented was a late-breaking study that revealed mechanical aortic valve replacements provide significant long-term survival benefits for patients aged 60 and younger, compared to bioprosthetic valves. The J. Maxwell Chamberlain Memorial Paper recently explored the comparative outcomes of ViV-TAVR versus redo-SAVR for patients with degenerated surgical bioprosthetic valves, highlighting the growing preference for ViV-TAVR due to its reduced surgical risk. Other sessions examined the risk of reoperation for both procedures, focusing on contributing factors such as mitral or tricuspid valve disease, advancements in cardiac surgery, new approaches to heart failure treatment, and innovations in structural heart interventions.

General Thoracic Surgery Sessions

Image
STS 2025 Dr. Seder

The General Thoracic sessions showcased groundbreaking advancements in the treatment of lung and esophageal cancers, emphasizing developments shaping the future of thoracic cancer care. The Clark Paper compared the survival outcomes of patients with non-small cell lung cancer who underwent lobectomy versus sublobar resection, focusing on the applicability of previous findings to a broader patient population. The J. Maxwell Chamberlain Memorial Paper examined the effectiveness of current lung cancer screening criteria and explored potential changes to improve them. Other areas explored included the extent of resection and quality metrics in lung cancer care, multimodal treatment of pleural mesothelioma after the MARS2 trial, and the future of lung cancer screening.

Congenital Heart Surgery Sessions

Presentations highlighted cutting-edge research and innovative approaches in the field of congenital heart surgery. The James S. Tweddell Memorial Paper focused on the relationship between hospital volume and patient outcomes for Norwood procedures. Another session explored the impact of specific factors on patient mortality in congenital heart surgery, demonstrating how large databases help identify potential predictors beyond traditional risk factors. Additional discussions included navigating congenital heart disease in premature newborns, challenges in clinical studies, and an analysis of long-term outcomes following the Ross Procedure.

Perioperative and Critical Care Sessions

The J. Maxwell Chamberlain Paper examined the impact of socioeconomic factors on the development of cardiac allograft vasculopathy (CAV) after heart transplantation, particularly in patients from disadvantaged backgrounds who face higher risks and poorer outcomes. Sessions also included a presentation on a newly developed risk model for predicting 90-day mortality after durable left ventricular assist device (dLVAD) implantation, based on real-world data to aid in patient selection and care improvement. Additional topics included structuring novel teams to improve cardiac emergency outcomes, controversies in anticoagulation and HIT after cardiac surgery, the changing landscape of heart and lung transplantation, and optimizing patient safety to enhance recovery after cardiac surgery.

Honoring Exceptional Women CT Surgeons

Image
STS 2025

More than 240 attendees gathered for the third annual Nina Starr Braunwald Extraordinary Women in Cardiothoracic Surgery Awards breakfast to celebrate women cardiothoracic surgeons who have exhibited outstanding clinical expertise and made significant contributions to the field. This year’s recipients were Jessica Donington, MD, UChicago Medicine; Stephanie Fuller, MD, Children’s Hospital of Philadelphia; and Aya Saito, MD, Yokohama City University.

Trailblazing Women Inspire at STS 2025

At STS 2025, attendees were captivated by three influential women showcasing excellence in their respective professions.

STS President Jennifer C. Romano, MD, MS, made history as the first woman surgeon to deliver the Presidential Address. In her speech, she reflected on her career journey, shared personal anecdotes, and recognized significant milestones in her professional life.

The inaugural Nina Starr Braunwald Lecture was delivered by Jennifer Doudna, PhD, a Nobel Prize-winning biochemist who co-discovered CRISPR-Cas9, a groundbreaking advancement in genetics and molecular biology. She shared her journey from scientific discovery to global impact, highlighting how innovation can shape the future of medicine.

Ami Vitale, an award-winning photojournalist and filmmaker, gave the Vivien Thomas Lecture.  During her talk, she shared impactful stories that highlighted healthcare, income, and housing disparities. Vitale stressed the importance of social responsibility and initiated meaningful discussions about caring for both people and the planet.

Hands-On Skill Building for Surgeons at All Levels

STS 2025 offered practical courses on various surgical procedures, providing an engaging and immersive learning experience for residents, early-career surgeons, and any surgeons seeking to enhance their skills. The topics included aortic annular enlargement, TEVAR techniques for aneurysms and dissections, mitral valve repair, complex central airway reconstruction, and the Ross procedure.

The Return of The Hub

For the second consecutive year, The Hub served as the focal point for early career surgeons, medical students, residents, and fellowship trainees. The Hub’s lounge area offered a variety of engaging sessions, including the White Coat Investor Talk, Mock Oral Interviews, Job Interview Preparation, Early Career Surgeon Roundtable Discussions, a Trainee Symposium with a luncheon, and more.

Image
STS 2025

Attendees also enjoyed creative activities in The Hub, such as the collaborative mural project “Splashes of Hope,” where participants contributed their creativity to artwork that will be donated to a local children's hospital. For those eager to capture memorable moments, the Selfie Station offered a fun and interactive backdrop perfect for sharing on social media. Additionally, a scavenger hunt inspired attendees to engage in challenges via the Annual Meeting app, with opportunities to win prizes.

Cutting-Edge Tools, Technologies, and Interactive Podcast Sessions

Image
STS 2025 Thinking Thoracic

The STS Annual Meeting exhibit hall featured more than 115 exhibitors showcasing the latest tools and technologies for surgical practice, along with live, hands-on product demonstrations. Industry symposia offered insights into emerging techniques and interventions. Two exhibit hall theaters provided attendees with the opportunity to experience live Thinking Thoracic and Same Surgeon, Different Light podcast shows, interactive industry presentations, and the CT Surgery Resident Showdown.

Annual Meeting Online Offers Continued Learning Experience

STS 2025 registrants receive complimentary access to Annual Meeting Online, where they can revisit presentations and recordings of missed sessions and earn additional CME credit. Annual Meeting Online is available for purchase at a significant discount for STS Members who did not attend, and access is free to all Resident/Fellow and Medical Student Members. Visit STS.org/AMonline to purchase.

 

Mar 18, 2025
6 min read

The Society of Thoracic Surgeons is thrilled to reassemble for its 61st Annual Meeting Jan. 24-26 in Los Angeles, which brings together cardiothoracic surgeons from around the globe and features late-breaking scientific research, cutting-edge technologies, innovative cardiothoracic surgery products, dynamic and interactive training, and impactful networking and mentorship opportunities.  

Image
Photo of the L.A. skyline
STS 2025 will take place in Los Angeles.

Held at the Los Angeles Convention Center, the meeting offers attendees — more than 2,000 professionals at all career stages— a seamless experience with plenary sessions, breakout sessions, and the exhibit hall all conveniently located. That makes it easy for attendees to navigate and connect with colleagues and industry leaders.

On Thursday, Jan. 23, three concurrent half-day pre-conference symposia will enhance the educational experience. These sessions will cover advancements in lung cancer, the diagnosis and treatment of aortic disease for patients of all ages, and more.

The first day of the Annual Meeting will kick off with the Nina Starr Braunwald Extraordinary Women in Cardiothoracic Surgery Awards breakfast. The event, co-hosted by STS and Women in Thoracic Surgery, will celebrate women cardiothoracic surgeons who have excelled in clinical practice, made significant contributions to the field, and demonstrated leadership, mentorship, integrity, creativity, and expertise.

The inaugural Nina Starr Braunwald Lecture will be presented by Jennifer Doudna, PhD, a Nobel Prize-winning biochemist renowned for her pioneering work in gene editing. She will explore how scientific innovation is shaping the future of medicine. The Vivien T. Thomas Lecture will feature award-winning photojournalist and filmmaker Ami Vitale. A passionate advocate for social responsibility, she will demonstrate how authentic storytelling can drive meaningful, positive change.

The Society will honor President Jennifer Romano, MD, MS, for her invaluable contributions to the organization as the first female president to hold the office. A special reception will be held at the Natural History Museum of Los Angeles County, amidst a majestic backdrop of North American wildlife dioramas that adorn the hall. Space is limited for this event, so attendees are encouraged to add the reception to their cart during registration.

STS 2025 will offer practical courses on various surgical procedures, delivering an engaging and immersive learning experience for residents, early career surgeons, and all surgeons seeking to enhance their skills. The topics include aortic annular enlargement, TEVAR techniques for aneurysms and dissections, mitral valve repair, complex central airway reconstruction, and the Ross procedure.

For the second consecutive year, The Hub will serve as the focal point for cardiothoracic surgery trainees. The Hub’s lounge area will offer a variety of engaging sessions, including mock oral Interviews, job interview preparation, early career surgeon roundtable discussions, a trainee symposium with a luncheon, and more.

Attendees can also enjoy creative activities in The Hub, such as the collaborative mural project “Splashes of Hope,” where participants can contribute their creativity to artwork that will be donated to a local children's hospital. For those eager to capture memorable moments, the selfie station will offer a fun and interactive backdrop perfect for sharing on social media. 

Additionally, a scavenger hunt will inspire attendees to engage in challenges via the Annual Meeting app, with opportunities to win prizes. 

There’s still time to register, add ticketed events, and start planning your Los Angeles experience at sts.org/annualmeeting

Jan 20, 2025
3 min read

On day one of STS 2024, meeting goers attended numerous sessions that explored the growing debate between SAVR and TAVR as treatment options,

"Dr. Michael Bowdish"
Dr. Michael Bowdish presents a late-breaking session on cardiac surgery after TAVR trends and outcomes.

"Improved Longitudinal Outcomes with Surgical Aortic Valve Replacement with Atrial Fibrillation Management over Transcatheter Aortic Valve Replacement Alone," part of the larger "Bring SAVR Back" session given by J Hunter Mehaffey, MD, unveiled Class I guideline recommendations that support atrial fibrillation (AF) treatment during surgical aortic valve replacement (SAVR). And how recently, many low to intermediate risk patients with AF and aortic stenosis (AS) are managed by transcatheter aortic valve replacement (TAVR). And finally, they evaluated real-world longitudinal outcomes of TAVR vs SAVR with or without AF treatment. 

"We concluded that in Medicare beneficiaries with AF who required aortic valve replacement, SAVR with concomitant treatment of AF was associated with improved longitudinal survival and freedom from stroke compared to TAVR," noted Dr. Mehaffey. "Consideration should be given for SAVR with AF treatment as a first-line approach for patients with AF requiring aortic valve replacement." 

In his discussion of "Robotic Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement: A Propensity Matched Analysis," Vikrant Jagadeesan, MD, presented findings on contemporary data that supports equipoise between surgical aortic valve replacement and transcatheter aortic valve replacement (TAVR) for the management of symptomatic severe aortic stenosis (AS). He further explained that controversy exists around the optimal management of patients in low to intermediate risk categories, and how the study compared outcomes of surgical robotic aortic valve replacement (RAVR) to TAVR. 

"Compared to TAVR, RAVR was associated with lower stroke and PPM rates, less PVL, and improved 1 year survival," said Dr. Jagadeesan. "And RAVR may provide a safe and effective minimally invasive first-line alternative for low to intermediate risk patients presenting with symptomatic AS."

In a late breaking session titled, "Cardiac Surgery after Transcatheter Aortic Valve Replacement: Trends and Outcomes," Michael Bowdish, MD, illustrated how his research team set out to document trends and outcomes in cardiac surgery following transcatheter aortic valve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase. Using the Society of Thoracic Surgeons Adult Cardiac Surgery Database, the study covers adult patients who underwent cardiac surgery after an initial TAVR from January 2012 to March 2023. 

"The study findings underscore the escalating need for both aortic and non-aortic valve cardiac surgeries following TAVR," explained Dr. Bowdish. "They note a substantial increase in the frequency of these surgeries, emphasizing the importance of understanding outcomes."  He observed elevated risk in these cases, as indicated by mortality and stroke rates, which calls for careful consideration, particularly given the expanding use of TAVR across a broader range of age and risk profiles. Finally, the study suggests the need for ongoing assessment and longitudinal evidence to inform decision-making in the evolving landscape of TAVR applications. 

Jan 27, 2024
3 min read

July 25, 2023, Chicago, Ill… The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess the risk of adult cardiac surgery operations.

Jul 25, 2023
Image
career development
Understand and embrace a hospital's decision-making process to get the products you need to perform at your best.
4 min read
Elisabeth Dexter, MD

Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. The GORE® TAG® Thoracic Branch Endoprosthesis (TBE) is single-branch aortic stent graft that provides an off-the-shelf solution for patients that need zone II aortic coverage and obviates the need for prior left subclavian revascularization. The Thoraflex Hybrid Frozen Elephant Trunk (FET) device is a pre-mated surgical graft and an aortic stent graft to facilitate single-stage treatment of arch and proximal descending aortic pathologies.

Date
Duration
1 hr. 7 min.
Image
Career Development Blog
As an early career surgeon, you don’t want to be left on an island without the backing of your partners and department leaders., Robert M. Van Haren, MD, MsPH
3 min read
Robert M. Van Haren, MD, MsPH

Cardiothoracic surgeons from the US and Italy receive practice-changing funding support

CHICAGO (January 19, 2022)—Through a collaborative effort between The Society of Thoracic Surgeons (STS) and the European Association for Cardio-Thoracic Surgery (EACTS), two standout young surgeons recently each received $20,000 in fellowship grants to learn new techniques used by institutions across the world.

Jan 19, 2022

Longtime society efforts advance connecting clinical outcomes and claims data 

WASHINGTON, DC (October 21, 2021) — The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) applaud Representatives Larry Bucshon, MD (R-IN), and Kim Schrier, MD (D-WA), for introducing the Meaningful Access to Federal Health Plan Claims Data Act of 2021.

Oct 21, 2021